Cell Counting Kit-8 Plus: Advanced WST-8 Based Cell Viability Assay

Executive Summary: The Cell Counting Kit-8 (CCK-8) Plus is an advanced assay for quantifying cell proliferation and cytotoxicity, employing a highly soluble tetrazolium salt (WST-8) that is enzymatically reduced in viable cells to yield a water-soluble orange formazan dye [APExBIO]. The generated formazan correlates linearly with cell number, enabling precise cell viability quantification. This kit demonstrates improved sensitivity, a broader linear detection range, and a shortened assay time (30–60 min) compared to traditional CCK-8 assays [Lu et al. 2025]. It is validated in applications involving airway epithelial cell response to pollutants and is essential for drug screening workflows [internal reference]. The kit maintains stability for up to 1 year at -20°C and at least 2 weeks at 4°C, making it practical for routine laboratory use.

Biological Rationale

Quantitative assessment of cell viability is central to many life science disciplines, including toxicology, pharmacology, and disease modeling. Accurate cell proliferation and cytotoxicity assays underpin evaluation of drug efficacy, pollutant toxicity, and cellular response to environmental stressors. Traditional assays such as MTT and XTT are limited by insoluble formazan products and multi-step protocols. The CCK-8 Plus assay leverages WST-8, which is reduced by cellular dehydrogenases to form a highly water-soluble formazan dye, enabling direct measurement of viable cell number in a single step [fluorometric.com]. In pulmonary research, rapid and sensitive detection of viability is crucial for modeling epithelial barrier disruption and inflammatory responses to airborne pollutants [Lu et al. 2025].

Mechanism of Action of Cell Counting Kit-8 (CCK-8) Plus

CCK-8 Plus utilizes the water-soluble tetrazolium salt WST-8. In metabolically active cells, WST-8 is reduced by cellular dehydrogenases (primarily mitochondrial) in the presence of an electron mediator, producing a soluble orange formazan dye. The absorbance of this dye at 450 nm is directly proportional to cell number. Unlike MTT, there is no need for solubilization steps, as the formazan remains in solution. The assay is non-radioactive, non-toxic, and can be performed in a homogeneous, single-well format. The reaction is typically complete within 0.5–1 hour at 37°C in standard culture medium, enabling rapid turnaround [APExBIO]. The amount of formazan produced reflects dehydrogenase activity, which correlates with viable cell number across a wide dynamic range (typically 100–50,000 cells/well in 96-well format).

Evidence & Benchmarks

• The CCK-8 Plus assay delivers a linear response for cell numbers between 100 and 50,000 cells/well in 96-well microplates, with R² > 0.99 under standard conditions (product page).
• In airway epithelial cell models, CCK-8 based assays detect non-cytotoxic pollutant exposures, enabling quantification of subtle changes in cell viability post O₃ or DEP exposure (Lu et al. 2025).
• Compared to traditional MTT/XTT assays, CCK-8 Plus reduces assay time by at least 50% and removes the need for solubilization, minimizing hands-on steps (internal article).
• Storage at -20°C ensures kit stability for up to 12 months; at 4°C, reagents remain stable for a minimum of 2 weeks, as verified by repeated standard curves (product page).
• Validated for high-throughput screening: used in drug cytotoxicity and proliferation studies requiring reproducibility across hundreds of plates (internal article).
• Assay is non-destructive, allowing subsequent downstream analyses such as RNA extraction or immunostaining from the same well (internal article).

Applications, Limits & Misconceptions

CCK-8 Plus is optimized for cell proliferation assays, cytotoxicity testing, drug screening, and dehydrogenase activity measurement. It is suitable for adherent and suspension cell lines, including primary cells. In pulmonary research, CCK-8 Plus enables quantification of airway cell responses to pollutants in air–liquid interface models, supporting mechanistic studies of barrier integrity and inflammation [Lu et al. 2025]. For a broader overview of how this assay updates and extends traditional workflows, see the related article on Cell Counting Kit-8 Plus: Transforming WST-8 Based Cell Viability Assays (this article provides new evidence and benchmark data specifically for airway models).

Common Pitfalls or Misconceptions

• CCK-8 Plus does not distinguish between proliferation and metabolic activation: increased signal may reflect higher dehydrogenase activity per cell, not just cell number.
• The assay is not suitable for samples containing strong reducing agents or compounds that may non-specifically reduce tetrazolium salts.
• Extremely high cell densities (>100,000 cells/well in 96-well plates) may saturate the response curve, leading to inaccurate quantification.
• Cells with very low metabolic activity may underreport viability even if physically intact.
• The assay is not validated for in vivo tissue samples or complex 3D matrices without prior optimization.

This article extends the insights in Cell Counting Kit-8 Plus: Advancing WST-8 Based Cell Viability by specifically detailing performance in pollutant-exposed airway models.

Workflow Integration & Parameters

To perform a CCK-8 Plus assay, add 10 µL of reagent directly to each well containing 100 µL of culture medium and incubate for 30–60 min at 37°C, shielded from light. After incubation, measure absorbance at 450 nm using a microplate reader. No washing or solubilization is required. The product (K2268) can be stored at -20°C for up to 1 year or at 4°C for 2 weeks for frequent use. For high-throughput drug screening, CCK-8 Plus is compatible with automation and multiwell formats. For further optimization strategies, see Cell Counting Kit-8 Plus: Optimizing WST-8 Based Cell Viability Assays, which this article updates with new performance data in air–liquid interface systems.

Conclusion & Outlook

Cell Counting Kit-8 (CCK-8) Plus from APExBIO sets a new standard for rapid, sensitive, and linear cell viability quantification. Its robust performance in air–liquid interface models positions it as a key tool for both mechanistic and translational research, especially in studies of pollutant-induced epithelial damage. The kit's streamlined workflow, broad dynamic range, and high reproducibility facilitate a wide array of applications, from basic research to high-throughput drug discovery. Future developments may include adaptation for complex 3D cultures and integration with multiplexed readouts for more nuanced interpretations of cell health.